Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE).

Moehler M, Heo J, Lee HC, Tak WY, Chao Y, Paik SW, Yim HJ, Byun KS, Baron A, Ungerechts G, Jonker D, Ruo L, Cho M, Kaubisch A, Wege H, Merle P, Ebert O, Habersetzer F, Blanc JF, Rosmorduc O, Lencioni R, Patt R, Leen AM, Foerster F, Homerin M, Stojkowitz N, Lusky M, Limacher JM, Hennequi M, Gaspar N, McFadden B, De Silva N, Shen D, Pelusio A, Kirn DH, Breitbach CJ, Burke JM.

Oncoimmunology. 2019 Jun 3;8(8):1615817. doi: 10.1080/2162402X.2019.1615817. eCollection 2019.

2.

Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.

Ricordel M, Foloppe J, Antoine D, Findeli A, Kempf J, Cordier P, Gerbaud A, Grellier B, Lusky M, Quemeneur E, Erbs P.

Cancers (Basel). 2018 Jul 10;10(7). pii: E231. doi: 10.3390/cancers10070231.

3.

Early isolated optic neuropathy caused by cyclosporine.

Mimouni K, Lusky M, Kramer M, Gdalevich M, Weinberger D, Mimouni M.

Int Ophthalmol. 2019 Apr;39(4):853-860. doi: 10.1007/s10792-018-0886-2. Epub 2018 Mar 12.

PMID:
29532216
4.

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes.

Heinrich B, Klein J, Delic M, Goepfert K, Engel V, Geberzahn L, Lusky M, Erbs P, Preville X, Moehler M.

Onco Targets Ther. 2017 May 2;10:2389-2401. doi: 10.2147/OTT.S126320. eCollection 2017.

5.

TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.

Dreno B, Urosevic-Maiwald M, Kim Y, Guitart J, Duvic M, Dereure O, Khammari A, Knol AC, Derbij A, Lusky M, Didillon I, Santoni AM, Acres B, Bataille V, Chenard MP, Bleuzen P, Limacher JM, Dummer R.

PLoS One. 2014 Feb 24;9(2):e83670. doi: 10.1371/journal.pone.0083670. eCollection 2014.

6.

Changes in anterior segment parameters after insertion of Ex-PRESS miniature glaucoma implant.

Hammel N, Lusky M, Kaiserman I, Robinson A, Bahar I.

J Glaucoma. 2013 Sep;22(7):565-8. doi: 10.1097/IJG.0b013e31824d4fa1.

PMID:
22407394
7.

Digital versus film stereo-photography for assessment of the optic nerve head in glaucoma and glaucoma suspect patients.

Hasanreisoglu M, Priel E, Naveh L, Lusky M, Weinberger D, Benjamini Y, Gaton DD.

J Glaucoma. 2013 Mar;22(3):238-42. doi: 10.1097/IJG.0b013e31823298da.

PMID:
21946551
8.

Oncolytic vaccinia virus: a silver bullet?

Lusky M, Erbs P, Foloppe J, Acres RB.

Expert Rev Vaccines. 2010 Dec;9(12):1353-6. doi: 10.1586/erv.10.137. No abstract available.

PMID:
21105770
9.

Effect of repeated applanation tonometry on the accuracy of intraocular pressure measurements.

Gaton DD, Ehrenberg M, Lusky M, Wussuki-Lior O, Dotan G, Weinberger D, Snir M.

Curr Eye Res. 2010 Jun;35(6):475-9. doi: 10.3109/02713681003678824.

PMID:
20465440
10.

Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.

Dias JD, Liikanen I, Guse K, Foloppe J, Sloniecka M, Diaconu I, Rantanen V, Eriksson M, Hakkarainen T, Lusky M, Erbs P, Escutenaire S, Kanerva A, Pesonen S, Cerullo V, Hemminki A.

Clin Cancer Res. 2010 May 1;16(9):2540-9. doi: 10.1158/1078-0432.CCR-09-2974. Epub 2010 Apr 13.

11.

Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.

Dummer R, Eichmüller S, Gellrich S, Assaf C, Dreno B, Schiller M, Dereure O, Baudard M, Bagot M, Khammari A, Bleuzen P, Bataille V, Derbij A, Wiedemann N, Waterboer T, Lusky M, Acres B, Urosevic-Maiwald M.

Mol Ther. 2010 Jun;18(6):1244-7. doi: 10.1038/mt.2010.52. Epub 2010 Apr 6.

12.

The novel Y371D myocilin mutation causes an aggressive form of juvenile open-angle glaucoma in a Caucasian family from the Middle-East.

Avisar I, Lusky M, Robinson A, Shohat M, Dubois S, Raymond V, Gaton DD.

Mol Vis. 2009 Sep 24;15:1945-50.

13.

[Enucleations and eviscerations in a large medical center between the years 1981 and 2007].

Gaton DD, Ehrlich R, Muzmacher L, Hamel N, Lusky M, Weinberger D.

Harefuah. 2008 Oct;147(10):758-62, 840. Hebrew.

PMID:
19039900
14.

Gene transfer into canine myoblasts.

Braun S, Thioudellet C, Perraud F, Escriou C, Claudepierre MC, Homann H, Lusky M, Mehtali M, Bischoff R, Pavirani A.

Cytotechnology. 1999 Jul;30(1-3):181-9. doi: 10.1023/A:1008026913715.

15.

Cellular localization and activity of Ad-delivered GFP-CFTR in airway epithelial and tracheal cells.

Granio O, Norez C, Ashbourne Excoffon KJ, Karp PH, Lusky M, Becq F, Boulanger P, Zabner J, Hong SS.

Am J Respir Cell Mol Biol. 2007 Dec;37(6):631-9. Epub 2007 Jul 19.

PMID:
17641299
16.

Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.

Rittner K, Schreiber V, Erbs P, Lusky M.

Cancer Gene Ther. 2007 May;14(5):509-18. Epub 2007 Feb 23.

PMID:
17318198
17.

The use of fibrin adhesive in trabeculectomy: a pilot study.

Bahar I, Lusky M, Gaton D, Robinson A, Avisar R, Weinberger D.

Br J Ophthalmol. 2006 Nov;90(11):1430. No abstract available.

18.

Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension.

Stiebel-Kalish H, Kalish Y, Lusky M, Gaton DD, Ehrlich R, Shuper A.

Am J Ophthalmol. 2006 Aug;142(2):279-83.

PMID:
16876509
19.

Fibrin glue as a suture substitute: histological evaluation of trabeculectomy in rabbit eyes.

Bahar I, Weinberger D, Lusky M, Avisar R, Robinson A, Gaton D.

Curr Eye Res. 2006 Jan;31(1):31-6.

PMID:
16421017
20.

Cyclocryotherapy versus transscleral diode laser cyclophotocoagulation for uncontrolled intraocular pressure.

Goldenberg-Cohen N, Bahar I, Ostashinski M, Lusky M, Weinberger D, Gaton DD.

Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):272-9.

PMID:
16156142
21.

Competitive quenching: a possible novel approach in protecting RPE cells from damage during PDT.

Weinberger D, Ron Y, Lusky M, Gaaton D, Orenstein A, Blank M, Mandel M, Livnat T, Barliya T, Lavie G.

Curr Eye Res. 2005 Apr;30(4):269-77.

PMID:
16020257
22.

Good manufacturing practice production of adenoviral vectors for clinical trials.

Lusky M.

Hum Gene Ther. 2005 Mar;16(3):281-91. Review.

PMID:
15812223
23.

Identification of the glycosylation site of the adenovirus type 5 fiber protein.

Cauet G, Strub JM, Leize E, Wagner E, Van Dorsselaer A, Lusky M.

Biochemistry. 2005 Apr 12;44(14):5453-60.

PMID:
15807538
24.

Plasminogen activator inhibitor-1 in the aqueous humor of patients with and without glaucoma.

Dan J, Belyea D, Gertner G, Leshem I, Lusky M, Miskin R.

Arch Ophthalmol. 2005 Feb;123(2):220-4.

PMID:
15710819
25.

Augmented trabeculectomy in paediatric glaucoma.

Ehrlich R, Snir M, Lusky M, Weinberger D, Friling R, Gaton DD.

Br J Ophthalmol. 2005 Feb;89(2):165-8.

26.

Swedish interactive thresholding algorithm fast for following visual fields in prepubertal idiopathic intracranial hypertension.

Stiebel-Kalish H, Lusky M, Yassur Y, Kalish Y, Shuper A, Erlich R, Lubman S, Snir M.

Ophthalmology. 2004 Sep;111(9):1673-5.

PMID:
15350321
27.

Pupillary block following posterior chamber intraocular lens implantation in adults.

Gaton DD, Mimouni K, Lusky M, Ehrlich R, Weinberger D.

Br J Ophthalmol. 2003 Sep;87(9):1109-11.

28.

Elevated intraocular pressure associated with steroid treatment for infantile spasms.

Friling R, Weinberger D, Zeharia A, Lusky M, Mimouni M, Gaaton D, Snir M.

Ophthalmology. 2003 Apr;110(4):831-4.

PMID:
12689911
29.

Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.

Van Linthout S, Lusky M, Collen D, De Geest B.

Gene Ther. 2002 Nov;9(22):1520-8.

30.

Transductional targeting with recombinant adenovirus vectors.

Legrand V, Leissner P, Winter A, Mehtali M, Lusky M.

Curr Gene Ther. 2002 Sep;2(3):323-39. Review.

PMID:
12189719
31.

Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.

Jornot L, Petersen H, Lusky M, Pavirani A, Moix I, Morris, Rochat T.

Endothelium. 2001;8(3):167-79.

PMID:
11824470
32.

Differential influence of the E4 adenoviral genes on viral and cellular promoters.

Grave L, Dreyer D, Dieterle A, Leroy P, Michou AI, Doderer C, Pavirani A, Lusky M, Mehtali M.

J Gene Med. 2000 Nov-Dec;2(6):433-43.

PMID:
11199264
33.

Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy.

Lerondel S, Le Pape A, Sené C, Faure L, Bernard S, Diot P, Nicolis E, Mehtali M, Lusky M, Cabrini G, Pavirani A.

Hum Gene Ther. 2001 Jan 1;12(1):1-11.

PMID:
11177537
34.

Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery.

Snir M, Lusky M, Shalev B, Gaton D, Weinberger D.

Ophthalmic Surg Lasers. 2000 Jan-Feb;31(1):31-7.

PMID:
10976558
35.

[Lowering intraocular pressure in glaucoma--by how much?].

Gaton DD, Lusky M, Yassur Y.

Harefuah. 1999 Jul;137(1-2):45-7. Review. Hebrew. No abstract available.

PMID:
10959277
36.

Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.

Christ M, Louis B, Stoeckel F, Dieterle A, Grave L, Dreyer D, Kintz J, Ali Hadji D, Lusky M, Mehtali M.

Hum Gene Ther. 2000 Feb 10;11(3):415-27.

PMID:
10697116
37.

Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.

Lusky M, Grave L, Dieterlé A, Dreyer D, Christ M, Ziller C, Furstenberger P, Kintz J, Hadji DA, Pavirani A, Mehtali M.

J Virol. 1999 Oct;73(10):8308-19.

38.

Intravitreal gas injection for hypotony after cataract surgery.

Weinberger D, Stiebel H, Lusky M, Hodish I, Yassur Y.

J Cataract Refract Surg. 1998 Nov;24(11):1490-2.

PMID:
9818339
39.

In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

Lusky M, Christ M, Rittner K, Dieterle A, Dreyer D, Mourot B, Schultz H, Stoeckel F, Pavirani A, Mehtali M.

J Virol. 1998 Mar;72(3):2022-32.

40.

A comparative study of two dose regimens of latanoprost in patients with elevated intraocular pressure.

Lusky M, Ticho U, Glovinsky J, Weinberger D, Nesher R, Yassur Y, Melamed S.

Ophthalmology. 1997 Oct;104(10):1720-4.

PMID:
9331215
41.

Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.

Christ M, Lusky M, Stoeckel F, Dreyer D, Dieterlé A, Michou AI, Pavirani A, Mehtali M.

Immunol Lett. 1997 Jun 1;57(1-3):19-25.

PMID:
9232420
42.

Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue.

Diestelhorst M, Krieglstein GK, Lusky M, Nagasubramanian S.

Surv Ophthalmol. 1997 Feb;41 Suppl 2:S77-81. Review.

PMID:
9154280
43.

Ultrasonographic findings of the optic disc in congenital glaucoma.

Snir M, Kremer I, Barash D, Lusky M, Yassur Y.

Ophthalmic Surg Lasers. 1996 Dec;27(12):1039-40.

PMID:
8976525
44.

Late visual field changes following cryotherapy for retinopathy of prematurity stage 3.

Kremer I, Nissenkorn I, Lusky M, Yassur Y.

Br J Ophthalmol. 1995 Mar;79(3):267-9.

45.

The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow.

Morsman CD, Bosem ME, Lusky M, Weinreb RN.

Eye (Lond). 1995;9 ( Pt 3):344-7.

PMID:
7556745
47.
48.

Anterior chamber angle configuration before and after iridotomy measured by scheimpflug video imaging.

Morsman CD, Lusky M, Bosem ME, Weinreb RN.

J Glaucoma. 1994 Summer;3(2):114-6.

PMID:
19920563
49.

Age-related changes in the human lens: a comparison of Scheimpflug photography and lens density index.

Bosem ME, Sample PA, Martinez GA, Lusky M, Weinreb RN.

J Cataract Refract Surg. 1994 Jan;20(1):70-3.

PMID:
8133484
50.

Supplemental Content

Support Center